{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:11:45Z","timestamp":1792890705671,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2020YFE0204300"],"award-info":[{"award-number":["2020YFE0204300"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82072314"],"award-info":[{"award-number":["82072314"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shandong Provincial Laboratory Project","award":["SYS202202"],"award-info":[{"award-number":["SYS202202"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["2022ZFJH003"],"award-info":[{"award-number":["2022ZFJH003"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"DOI":"10.1186\/s12941-025-00827-2","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T08:51:47Z","timestamp":1760431907000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Resistance profile and influence factors of carbapenem-resistant Klebsiella pneumoniae (CRKP) causing infections in China: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiaolu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghao","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beiwen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanxi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiawei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"827_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10010056","author":"D Mil-Homens","year":"2021","unstructured":"Mil-Homens D, Martins M, Barbosa J, Serafim G, Sarmento MJ, Pires RF, et al. Carbapenem-resistant Klebsiella pneumoniae clinical isolates. In vivo virulence assessment in Galleria mellonella and potential therapeutics by polycationic oligoethyleneimine. Antibiotics. 2021. https:\/\/doi.org\/10.3390\/antibiotics10010056.","journal-title":"Antibiotics"},{"key":"827_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.750662","volume":"12","author":"D Chang","year":"2021","unstructured":"Chang D, Sharma L, Dela CC, Zhang D. Clinical Epidemiology, Risk Factors, and Control Strategies of Klebsiella pneumoniae Infection. Front Microbiol. 2021;12:750662. https:\/\/doi.org\/10.3389\/fmicb.2021.750662.","journal-title":"Front Microbiol"},{"key":"827_CR3","unstructured":"WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance, 2025(2025\/3\/30). https:\/\/www.who.int\/publications\/i\/item\/9789240093461"},{"issue":"4","key":"827_CR4","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1128\/AAC.45.4.1151-1161.2001","volume":"45","author":"H Yigit","year":"2001","unstructured":"Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45(4):1151\u201361. https:\/\/doi.org\/10.1128\/AAC.45.4.1151-1161.2001.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"827_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1128\/AAC.01053-06","volume":"51","author":"Z Wei","year":"2007","unstructured":"Wei Z, Du X, Yu Y, Shen P, Chen Y, Li L. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother. 2007;51(2):763\u20135. https:\/\/doi.org\/10.1128\/AAC.01053-06.","journal-title":"Antimicrob Agents Chemother"},{"key":"827_CR6","unstructured":"CHINET. Resistance changes of Klebsiella pneumoniae to imipenem and meropenem. https:\/\/www.chinets.com\/Data\/AntibioticDrugFast"},{"key":"827_CR7","doi-asserted-by":"publisher","unstructured":"Zhen X, Stalsby LC, Sun X, Gu S, Dong H. Clinical and economic burden of carbapenem-resistant infection or colonization caused by Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii: a multicenter study in China. Antibiotics (Basel). 2020;9(8). https:\/\/doi.org\/10.3390\/antibiotics9080514.","DOI":"10.3390\/antibiotics9080514"},{"issue":"1","key":"827_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12941-017-0191-3","volume":"16","author":"L Xu","year":"2017","unstructured":"Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16(1):18. https:\/\/doi.org\/10.1186\/s12941-017-0191-3.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"827_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12020234","author":"T Karampatakis","year":"2023","unstructured":"Karampatakis T, Tsergouli K, Behzadi P. Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics. 2023. https:\/\/doi.org\/10.3390\/antibiotics12020234.","journal-title":"Antibiotics"},{"issue":"6","key":"827_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004233","volume":"20","author":"Y Hu","year":"2023","unstructured":"Hu Y, Yang Y, Feng Y, Fang Q, Wang C, Zhao F, et al. Prevalence and clonal diversity of carbapenem-resistant Klebsiella pneumoniae causing neonatal infections: a systematic review of 128 articles across 30 countries. PLoS Med. 2023;20(6):e1004233. https:\/\/doi.org\/10.1371\/journal.pmed.1004233.","journal-title":"PLoS Med"},{"issue":"3","key":"827_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00283-21","volume":"9","author":"P Fu","year":"2021","unstructured":"Fu P, Xu H, Jing C, Deng J, Wang H, Hua C, et al. Bacterial epidemiology and antimicrobial resistance profiles in children reported by the ISPED program in China, 2016 to 2020. Microbiol Spectrum. 2021;9(3):e28321. https:\/\/doi.org\/10.1128\/spectrum.00283-21.","journal-title":"Microbiol. Spectrum"},{"key":"827_CR12","doi-asserted-by":"publisher","unstructured":"Chen J, Ma H, Huang X, Cui Y, Peng W, Zhu F, Ma S, Rao M, Zhang P, Yang H, Su L, Niu R, Pan P. Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study. Antimicrobial Resistance Infection Control. 2022;11(1). https:\/\/doi.org\/10.1186\/s13756-022-01204-w.","DOI":"10.1186\/s13756-022-01204-w"},{"key":"827_CR13","doi-asserted-by":"publisher","first-page":"7289","DOI":"10.2147\/IDR.S436284","volume":"16","author":"W Cai","year":"2023","unstructured":"Cai W, Kang J, Ma Y, Yin D, Song Y, Liu Y, et al. Molecular epidemiology of carbapenem resistant Klebsiella pneumoniae in Northern China: clinical characteristics, antimicrobial resistance, virulence and geographic distribution. Infect Drug Resist. 2023;16:7289\u2013304. https:\/\/doi.org\/10.2147\/IDR.S436284.","journal-title":"Infect Drug Resist"},{"issue":"5","key":"827_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1089\/mdr.2018.0401","volume":"26","author":"L Zeng","year":"2020","unstructured":"Zeng L, Deng Q, Zeng T, Liu Y, Zhang J, Cao X. Prevalence of carbapenem-resistant Klebsiella pneumoniae infection in Southern China: clinical characteristics, antimicrobial resistance, virulence, and geographic distribution. Microb Drug Resist. 2020;26(5):483\u201391. https:\/\/doi.org\/10.1089\/mdr.2018.0401.","journal-title":"Microb Drug Resist"},{"key":"827_CR15","doi-asserted-by":"publisher","first-page":"1132323","DOI":"10.3389\/fpubh.2023.1132323","volume":"11","author":"H Huang","year":"2023","unstructured":"Huang H, Wu K, Chen H, Wang J, Chen L, Lai Z, et al. The impact of the COVID-19 pandemic on nosocomial infections: a retrospective analysis in a tertiary maternal and child healthcare hospital. Front Public Health. 2023;11:1132323. https:\/\/doi.org\/10.3389\/fpubh.2023.1132323.","journal-title":"Front Public Health"},{"issue":"2","key":"827_CR16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s40121-022-00751-4","volume":"12","author":"Q Meng","year":"2023","unstructured":"Meng Q, Li W, Jiang H, Yan H, Wang H, Ye B, et al. Comparison of the distribution and changes in the antibiotic resistance of clinical bacterial isolates from the lower respiratory tract of children in Shenzhen before the epidemic, during the epidemic, and during the period of normalized prevention and control of COVID-19. Infect Dis Ther. 2023;12(2):563\u201375. https:\/\/doi.org\/10.1007\/s40121-022-00751-4.","journal-title":"Infect Dis Ther"},{"issue":"1","key":"827_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1732232","volume":"9","author":"S Zhan","year":"2020","unstructured":"Zhan S, Yang YY, Fu C. Public\u2019s early response to the novel coronavirus-infected pneumonia. Emerg Microbes Infect. 2020;9(1):534. https:\/\/doi.org\/10.1080\/22221751.2020.1732232.","journal-title":"Emerg Microbes Infect"},{"key":"827_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11040535","author":"K Jeon","year":"2022","unstructured":"Jeon K, Jeong S, Lee N, Park MJ, Song W, Kim HS, et al. Impact of COVID-19 on antimicrobial consumption and spread of multidrug-resistance in bacterial infections. Antibiotics. 2022. https:\/\/doi.org\/10.3390\/antibiotics11040535.","journal-title":"Antibiotics"},{"key":"827_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12081285","author":"J Ficik","year":"2023","unstructured":"Ficik J, Andrezal M, Drahovska H, Bohmer M, Szemes T, Liptakova A, et al. Carbapenem-resistant Klebsiella pneumoniae in COVID-19 era-challenges and solutions. Antibiotics. 2023. https:\/\/doi.org\/10.3390\/antibiotics12081285.","journal-title":"Antibiotics"},{"issue":"4","key":"827_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106324","volume":"57","author":"CC Lai","year":"2021","unstructured":"Lai CC, Chen SY, Ko WC, Hsueh PR. Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents. 2021;57(4):106324. https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106324.","journal-title":"Int J Antimicrob Agents"},{"key":"827_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101083","volume":"74","author":"Q Wang","year":"2024","unstructured":"Wang Q, Wang R, Wang S, Zhang A, Duan Q, Sun S, et al. Expansion and transmission dynamics of high risk carbapenem-resistant Klebsiella pneumoniae subclones in China: an epidemiological, spatial, genomic analysis. Drug Resist Updat. 2024;74:101083. https:\/\/doi.org\/10.1016\/j.drup.2024.101083.","journal-title":"Drug Resist Updat"},{"key":"827_CR22","unstructured":"Agency for Healthcare Research and Quality, 2024(2024\/6\/26). https:\/\/www.ahrq.gov\/"},{"key":"827_CR23","unstructured":"M100 Ed34. Performance Standards for Antimicrobial Susceptibility Testing, 34th Edition, 2024(2024\/6\/26). https:\/\/webstore.ansi.org\/standards\/clsi\/clsim100ed34"},{"key":"827_CR24","unstructured":"Viswanathan M, Ansari MT, Berkman ND, Chang S, Hartling L, McPheeters M, Santaguida PL, Shamliyan T, Singh K, Tsertsvadze A, Treadwell JR. Assessing the risk of bias of individual studies in systematic reviews of health care interventions. 2008."},{"issue":"2","key":"827_CR25","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02290-21","volume":"10","author":"AV Cienfuegos-Gallet","year":"2022","unstructured":"Cienfuegos-Gallet AV, Zhou Y, Ai W, Kreiswirth BN, Yu F, Chen L. Multicenter genomic analysis of carbapenem-resistant klebsiella pneumoniae from bacteremia in China. Microbiol Spectr. 2022;10(2):e229021. https:\/\/doi.org\/10.1128\/spectrum.02290-21.","journal-title":"Microbiol Spectr"},{"key":"827_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103998","volume":"79","author":"N Dong","year":"2022","unstructured":"Dong N, Yang X, Chan EW, Zhang R, Chen S. Klebsiella species: taxonomy, hypervirulence and multidrug resistance. EBioMedicine. 2022;79:103998. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103998.","journal-title":"EBioMedicine"},{"issue":"1","key":"827_CR27","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1080\/22221751.2020.1799721","volume":"9","author":"Y Hu","year":"2020","unstructured":"Hu Y, Liu C, Shen Z, Zhou H, Cao J, Chen S, et al. Prevalence, risk factors and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in patients from Zhejiang, China, 2008\u20132018. Emerg Microbes Infect. 2020;9(1):1771\u20139. https:\/\/doi.org\/10.1080\/22221751.2020.1799721.","journal-title":"Emerg Microbes Infect"},{"issue":"9","key":"827_CR28","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","volume":"13","author":"LS Munoz-Price","year":"2013","unstructured":"Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13(9):785\u201396. https:\/\/doi.org\/10.1016\/S1473-3099(13)70190-7.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"827_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/jac\/dkq431","volume":"66","author":"Y Qi","year":"2011","unstructured":"Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother. 2011;66(2):307\u201312. https:\/\/doi.org\/10.1093\/jac\/dkq431.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"827_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijantimicag.2019.03.014","volume":"54","author":"P Fu","year":"2019","unstructured":"Fu P, Tang Y, Li G, Yu L, Wang Y, Jiang X. Pandemic spread of bla((KPC-2)) among Klebsiella pneumoniae ST11 in China is associated with horizontal transfer mediated by IncFII-like plasmids. Int J Antimicrob Agents. 2019;54(2):117\u201324. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.03.014.","journal-title":"Int J Antimicrob Agents"},{"key":"827_CR31","doi-asserted-by":"publisher","unstructured":"Li L, Jiang Z, Wang X, Yang S, Li F, Xiao Y, Qu J. Carbapenem-resistant Klebsiella pneumoniae ST11 index from a single strain enhances rapid parallel evolution during persistent infection. hLife. 2025. https:\/\/doi.org\/10.1016\/j.hlife.2025.04.007.","DOI":"10.1016\/j.hlife.2025.04.007"},{"issue":"4","key":"827_CR32","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02572-21","volume":"10","author":"X Han","year":"2022","unstructured":"Han X, Chen Y, Zhou J, Shi Q, Jiang Y, Wu X, et al. Epidemiological characteristics of OXA-232-producing carbapenem-resistant klebsiella pneumoniae strains isolated during nosocomial clonal spread associated with environmental colonization. Microbiol Spectr. 2022;10(4):e257221. https:\/\/doi.org\/10.1128\/spectrum.02572-21.","journal-title":"Microbiol Spectr"},{"issue":"2","key":"827_CR33","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03213-22","volume":"11","author":"M Jiang","year":"2023","unstructured":"Jiang M, Li H, Liu X, Shen N, Zhou Y, Song W, et al. Genomic analysis revealed the international and domestic transmission of carbapenem-resistant klebsiella pneumoniae in chinese pediatric patients. Microbiol Spectr. 2023;11(2):e321322. https:\/\/doi.org\/10.1128\/spectrum.03213-22.","journal-title":"Microbiol Spectr"},{"issue":"4","key":"827_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10096-020-04063-8","volume":"40","author":"K Rothe","year":"2021","unstructured":"Rothe K, Feihl S, Schneider J, Wallnofer F, Wurst M, Lukas M, et al. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship. Eur J Clin Microbiol Infect Dis. 2021;40(4):859\u201369. https:\/\/doi.org\/10.1007\/s10096-020-04063-8.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"827_CR35","doi-asserted-by":"publisher","unstructured":"Despotovic A, Barac A, Cucanic T, Cucanic K, Stevanovic G. Antibiotic (Mis)Use in COVID-19 Patients before and after Admission to a Tertiary Hospital in Serbia. Antibiotics (Basel). 2022;11(7). https:\/\/doi.org\/10.3390\/antibiotics11070847.","DOI":"10.3390\/antibiotics11070847"},{"issue":"1","key":"827_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13756-025-01567-w","volume":"14","author":"T Wu","year":"2025","unstructured":"Wu T, Li T, Guo H, Zhu B, Zhang Y, Zhao Z. Trends of antibiotic use for acute upper respiratory infections in Chinese emergency departments and the impact of COVID-19: a cross-sectional study. Antimicrob Resist Infect Control. 2025;14(1):51. https:\/\/doi.org\/10.1186\/s13756-025-01567-w.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"827_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s43168-023-00193-7","volume":"17","author":"MM Hussein","year":"2023","unstructured":"Hussein MM, Shaheen MA, Sleem AM, Mahmoud FM, Ishak SR. Increased antimicrobial resistance in bacterial pneumonia among Egyptian children during the COVID-19 pandemic. Egypt J Bronchol. 2023;17(1):17. https:\/\/doi.org\/10.1186\/s43168-023-00193-7.","journal-title":"Egypt J Bronchol"},{"issue":"4","key":"827_CR38","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","volume":"27","author":"BJ Langford","year":"2021","unstructured":"Langford BJ, So M, Raybardhan S, Leung V, Soucy JR, Westwood D, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021;27(4):520\u201331. https:\/\/doi.org\/10.1016\/j.cmi.2020.12.018.","journal-title":"Clin Microbiol Infect"},{"key":"827_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jgar.2019.12.009","volume":"22","author":"Y Wang","year":"2020","unstructured":"Wang Y, Wang J, Wang R, Cai Y. Resistance to ceftazidime-avibactam and underlying mechanisms. J Glob Antimicrob Resist. 2020;22:18\u201327. https:\/\/doi.org\/10.1016\/j.jgar.2019.12.009.","journal-title":"J Glob Antimicrob Resist"},{"key":"827_CR40","doi-asserted-by":"publisher","unstructured":"Li X, Ke H, Wu W, Tu Y, Zhou H, Yu Y. Molecular mechanisms driving the in vivo development of KPC-71-Mediated resistance to ceftazidime-avibactam during treatment of carbapenem-resistant klebsiella pneumoniae infections. mSphere. 2021;6(6):e85921. https:\/\/doi.org\/10.1128\/mSphere.00859-21.","DOI":"10.1128\/mSphere.00859-21"},{"issue":"2","key":"827_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3855\/jidc.11938","volume":"14","author":"Y Xu","year":"2020","unstructured":"Xu Y, Lu J, Sun C, Wang X, Hu YJ, Zhou X. A cross-sectional study of antibiotic misuse among Chinese children in developed and less developed provinces. J Infect Dev Ctries. 2020;14(2):129\u201337. https:\/\/doi.org\/10.3855\/jidc.11938.","journal-title":"J Infect Dev Ctries"},{"issue":"15","key":"827_CR42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1717295115","volume":"115","author":"EY Klein","year":"2018","unstructured":"Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A. 2018;115(15):E3463\u2013E3470. https:\/\/doi.org\/10.1073\/pnas.1717295115.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"827_CR43","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1080\/14787210.2022.2099375","volume":"20","author":"KB Laupland","year":"2022","unstructured":"Laupland KB. Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria. Expert Rev Anti-Infect Ther. 2022;20(9):1171\u20138. https:\/\/doi.org\/10.1080\/14787210.2022.2099375.","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"1","key":"827_CR44","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/0366-6999.221267","volume":"131","author":"Z Wang","year":"2018","unstructured":"Wang Z, Qin RR, Huang L, Sun LY. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection and mortality of Klebsiella pneumoniae infection. Chin Med J (Engl). 2018;131(1):56\u201362. https:\/\/doi.org\/10.4103\/0366-6999.221267.","journal-title":"Chin Med J (Engl)"},{"key":"827_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12040718","author":"L Schramm","year":"2023","unstructured":"Schramm L, Byrne MK, Sweetnam T. Antibiotic misuse behaviours of older people: confirmation of the factor structure of the antibiotic use questionnaire. Antibiotics. 2023. https:\/\/doi.org\/10.3390\/antibiotics12040718.","journal-title":"Antibiotics"},{"issue":"23","key":"827_CR46","doi-asserted-by":"publisher","first-page":"13942","DOI":"10.1021\/acs.est.8b03979","volume":"52","author":"H Wang","year":"2018","unstructured":"Wang H, Yang J, Yu X, Zhao G, Zhao Q, Wang N, et al. Exposure of adults to antibiotics in a Shanghai suburban area and health risk assessment: a biomonitoring-based study. Environ Sci Technol. 2018;52(23):13942\u201350. https:\/\/doi.org\/10.1021\/acs.est.8b03979.","journal-title":"Environ Sci Technol"},{"key":"827_CR47","doi-asserted-by":"publisher","unstructured":"Robles Aguilar G, Altay U, Giannakis K, Fell F, Abdelkader A, Addo IY, Adeyeoluwa TE, Al Thaher Y, Alalalmeh SO, Alhaji NB, Al-Zyoud WA, Anvari S, Atout MMW, Baig AA, Baker S, Bardhan M, Basharat Z, Bastard M, Bhagavathula AS, Brown CS, Cenderadewi M, Chakraborty S, Chopra H, Chutiyami M, Da Silva AG, De la Hoz FP, Dekker DM, Elias C, Eshrati B, Fahim A, Fakhri-Demeshghieh A, Fatehizadeh A, Gajd\u00e1cs M, Gebremeskel TG, Haller S, Harapan H, Haselbeck AH, Hassan S, Hayat K, He J, Hostiuc S, Hussein NR, Huy LD, Iwu CD, Iwu-Jaja CJ, Jawaid T, Khamesipour F, Khusuwan S, Krapp F, Kuddus M, Lawal BK, Lerango TL, Lim SS, Makram OM, Marks F, Mougin V, Mukoro GD, Nainu F, Nchanji GT, Negoi RI, Nejadghaderi SA, Ochoa TJ, Ojo-Akosile TR, Okeke SR, Olivas-Martinez A, Olorukooba AAPAMP, Patel J, Rahbarnia L, Rahim F, Rahman M, Rahman MA, Ramteke PW, Rana RK, Reyes LF, Roberts T, Rosenthal VD, Sahu M, Samy AM, Sedighi M, Shetty M, Shittu A, Silva LMLR, Sim\u00f5es EAF, Singh S, Stoeva TZ, Taha ZM, Tan K, Tasak N, Tat NY, Thangaraju P, Turner P, Udoh A, Weerakoon KG, Yaghoubi S, Yuan C, Zhang H, Stergachis A, Cooper BS, Murray CJL, GBD ARC. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet (British Edn). 2024;404(10459):1199\u2013226. https:\/\/doi.org\/10.1016\/S0140-6736(24)01867-1.","DOI":"10.1016\/S0140-6736(24)01867-1"},{"issue":"5","key":"827_CR48","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jinf.2022.03.010","volume":"84","author":"T Lou","year":"2022","unstructured":"Lou T, Du X, Zhang P, Shi Q, Han X, Lan P, et al. Risk factors for infection and mortality caused by carbapenem-resistant Klebsiella pneumoniae: a large multicentre case-control and cohort study. J Infect. 2022;84(5):637\u201347. https:\/\/doi.org\/10.1016\/j.jinf.2022.03.010.","journal-title":"J Infect"},{"key":"827_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.818308","volume":"11","author":"J Chen","year":"2021","unstructured":"Chen J, Yang Y, Yao H, Bu S, Li L, Wang F, et al. Prediction of prognosis in adult patients with Carbapenem-resistant Klebsiella pneumoniae infection. Front Cell Infect Microbiol. 2021;11:818308. https:\/\/doi.org\/10.3389\/fcimb.2021.818308.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"827_CR50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1179\/2047773215Y.0000000004","volume":"109","author":"Y Jiao","year":"2015","unstructured":"Jiao Y, Qin Y, Liu J, Li Q, Dong Y, Shang Y, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection\/colonization and predictors of mortality: a retrospective study. Pathog Glob Health. 2015;109(2):68\u201374. https:\/\/doi.org\/10.1179\/2047773215Y.0000000004.","journal-title":"Pathog Glob Health"},{"key":"827_CR51","doi-asserted-by":"publisher","first-page":"6767","DOI":"10.2147\/IDR.S431085","volume":"16","author":"C Zhou","year":"2023","unstructured":"Zhou C, Sun L, Li H, Huang L, Liu X. Risk factors and mortality of elderly patients with hospital-acquired pneumonia of carbapenem-resistant Klebsiella pneumoniae infection. Infect Drug Resist. 2023;16:6767\u201379. https:\/\/doi.org\/10.2147\/IDR.S431085.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"827_CR52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jhin.2015.06.018","volume":"92","author":"A Hoxha","year":"2016","unstructured":"Hoxha A, K\u00e4rki T, Giambi C, Montano C, Sisto A, Bella A, et al. Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012\u20132013. J Hosp Infect. 2016;92(1):61\u20136. https:\/\/doi.org\/10.1016\/j.jhin.2015.06.018.","journal-title":"J Hosp Infect"},{"issue":"11","key":"827_CR53","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1017\/ice.2017.197","volume":"38","author":"PP Kohler","year":"2017","unstructured":"Kohler PP, Volling C, Green K, Uleryk EM, Shah PS, McGeer A. Carbapenem resistance, initial antibiotic therapy, and mortality in Klebsiella pneumoniae bacteremia: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2017;38(11):1319\u201328. https:\/\/doi.org\/10.1017\/ice.2017.197.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"827_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-020-00728-3","volume":"9","author":"Y Li","year":"2020","unstructured":"Li Y, Li J, Hu T, Hu J, Song N, Zhang Y, et al. Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China. Antimicrob Resist Infect Control. 2020;9(1):79. https:\/\/doi.org\/10.1186\/s13756-020-00728-3.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"9","key":"827_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-025-04405-0","volume":"207","author":"SK Dwibedy","year":"2025","unstructured":"Dwibedy SK, Padhy I, Bitode GM, Mohapatra SS. Prevalence of polymyxin heteroresistance in Klebsiella pneumoniae under sustained antibiotic selection during experimental evolution. Arch Microbiol. 2025;207(9):201. https:\/\/doi.org\/10.1007\/s00203-025-04405-0.","journal-title":"Arch Microbiol"},{"key":"827_CR56","unstructured":"Sun H, Zhang YC, Shangguan ZK, Zhang Y, Fan RL, Li H, Guan SL, Zhang LB. Research progress on the variation characteristics and dissemination of colistin resistance genes. Acta Veterinaria et Zootechnica Sinica. 2018;49(10):2102\u201311."},{"issue":"3","key":"827_CR57","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00381-22","volume":"10","author":"PH Huang","year":"2022","unstructured":"Huang PH, Chen WY, Chou SH, Wang FD, Lin YT. Risk factors for the development of colistin resistance during colistin treatment of carbapenem-resistant klebsiella pneumoniae infections. Microbiol Spectr. 2022;10(3):e38122. https:\/\/doi.org\/10.1128\/spectrum.00381-22.","journal-title":"Microbiol Spectr"},{"key":"827_CR58","doi-asserted-by":"publisher","first-page":"5603","DOI":"10.2147\/IDR.S342163","volume":"14","author":"F Chen","year":"2021","unstructured":"Chen F, Zhong H, Yang T, Shen C, Deng Y, Han L, et al. Ceftazidime-avibactam as salvage treatment for infections due to carbapenem-resistant Klebsiella pneumoniae in liver transplantation recipients. Infect Drug Resist. 2021;14:5603\u201312. https:\/\/doi.org\/10.2147\/IDR.S342163.","journal-title":"Infect Drug Resist"},{"key":"827_CR59","doi-asserted-by":"publisher","unstructured":"Tumbarello M, Raffaelli F, Giannella M, Mantengoli E, Mularoni A, Venditti M, De Rosa FG, Sarmati L, Bassetti M, Brindicci G, Rossi M, Luzzati R, Grossi PA, Corona A, Capone A, Falcone M, Mussini C, Trecarichi EM, Cascio A, Guffanti E, Russo A, De Pascale G, Tascini C, Gentile I, Losito AR, Bussini L, Corti G, Ceccarelli G, Corcione S, Compagno M, Giacobbe DR, Saracino A, Fantoni M, Antinori S, Peghin M, Bonfanti P, Oliva A, De Gasperi A, Tiseo G, Rovelli C, Meschiari M, Shbaklo N, Spanu T, Cauda R, Viale P. Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing K. pneumoniae infections: a retrospective observational multicenter study. Clin Infect Dis. 2021;73(9):1664\u20131676. https:\/\/doi.org\/10.1093\/cid\/ciab176.","DOI":"10.1093\/cid\/ciab176"},{"issue":"2","key":"827_CR60","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/cid\/cix783","volume":"66","author":"D van Duin","year":"2018","unstructured":"van Duin D, Lok JJ, Earley M, Cober E, Richter SS, Perez F, et al. Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant enterobacteriaceae. Clin Infect Dis. 2018;66(2):163\u201371. https:\/\/doi.org\/10.1093\/cid\/cix783.","journal-title":"Clin Infect Dis"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-025-00827-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-025-00827-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-025-00827-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T08:51:53Z","timestamp":1760431913000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-025-00827-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["827"],"URL":"https:\/\/doi.org\/10.1186\/s12941-025-00827-2","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"19 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}